Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FDSTS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,674
Award facts
- Contract value 100% obligated
- $15,673.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,673.80 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 28, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As the prime contractor on this arrangement, the company leverages its substantial IDC with DLA to deliver a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. The non-set-aside competitive awards in AmerisourceBergen's portfolio demonstrate its established capability to meet federal procurement requirements and deliver essential medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FDSTS?
SPE2DB26FDSTS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FDSTS worth?
The government has obligated $15,674 on SPE2DB26FDSTS.
Is contract SPE2DB26FDSTS an order under another contract?
Yes. SPE2DB26FDSTS is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSTS competed?
The extent of competition for SPE2DB26FDSTS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award